Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-06 4:05 pm Sale | 13G | TRANSCODE THERAPEUTICS INC RNAZ | 3i LP | 0 0.000% | -1,716,600 (Position Closed) | View |
2024-07-26 4:05 pm Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | 3i LP | 1,716,600 9.900% | 1,716,600 (New Position) | View |
2024-06-21 4:02 pm Purchase | 13D | TRANSCODE THERAPEUTICS INC RNAZ | Fitzgerald Thomas A | 422,036 5.500% | 422,036 (New Position) | View |
2024-02-15 4:00 pm Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Medarova Zdravka | 112,077 0.400% | 112,077 (New Position) | View |
2024-02-14 4:00 pm Sale | 13G | TRANSCODE THERAPEUTICS INC RNAZ | TANG CAPITAL PARTNERS LP | 0 0.000% | -354,700 (Position Closed) | View |
2024-02-13 8:12 pm Sale | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Lind Global Fund II LP | 26,279 0.100% | -2,473,721 (-98.95%) | View |
2023-12-07 4:30 pm Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Lind Global Fund II LP | 2,500,000 9.900% | 2,500,000 (New Position) | View |
2023-10-10 4:00 pm Purchase | 13D | TRANSCODE THERAPEUTICS INC RNAZ | Dudley Robert Michael | 227,743 1.900% | 116,209 (+104.19%) | View |
2023-09-26 11:06 am Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | TANG CAPITAL PARTNERS LP | 354,700 9.990% | 354,700 (New Position) | View |
2023-06-16 4:00 pm Purchase | 13D | TRANSCODE THERAPEUTICS INC RNAZ | Dudley Robert Michael | 111,534 6.000% | 111,534 (New Position) | View |
2023-02-10 08:00 am Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Medarova Zdravka | 1,660,739 12.700% | 42,242 (+2.61%) | View |
2022-12-19 5:36 pm Purchase | 13D | TRANSCODE THERAPEUTICS INC RNAZ | Dudley Robert Michael | 1,756,516 12.700% | 323,147 (+22.54%) | View |
2022-12-19 5:33 pm Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Medarova Zdravka | 1,618,497 12.500% | 1,618,497 (New Position) | View |
2022-12-19 5:32 pm Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Dudley Robert Michael | 1,433,369 10.600% | 1,433,369 (New Position) | View |
2022-10-27 08:08 am Sale | 13G | TRANSCODE THERAPEUTICS INC RNAZ | HIRSCHMAN ORIN | 0 0.000% | -1,289,000 (Position Closed) | View |
2022-02-11 3:06 pm Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | HIRSCHMAN ORIN | 1,289,000 9.900% | 18,500 (+1.46%) | View |
2021-07-20 5:55 pm Purchase | 13G | TRANSCODE THERAPEUTICS INC RNAZ | HIRSCHMAN ORIN | 1,270,500 9.900% | 1,270,500 (New Position) | View |